Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study by Liu, Joyce F, Dr, Barry, William T, PhD, Birrer, Michael, MD, Lee, Jung-Min, MD, Buckanovich, Ronald J, MD, Fleming, Gini F, Prof, Rimel, BJ, MD, Buss, Mary K, MD, Nattam, Sreenivasa, MD, Hurteau, Jean, MD, Luo, Weixiu, MS, Quy, Philippa, MA, Whalen, Christin, BSN, Obermayer, Lisa, BA, Lee, Hang, PhD, Winer, Eric P, Prof, Kohn, Elise C, MD, Ivy, S Percy, MD, Matulonis, Ursula A, MD

Get full text

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors by Steingart, Richard M., MD, Bakris, George L., MD, Chen, Helen X., MD, Chen, Ming-Hui, MD, MMSc, Force, Thomas, MD, Ivy, S. Percy, MD, Leier, Carl V., MD, Liu, Glenn, MD, Lenihan, Daniel, MD, Lindenfeld, JoAnn, MD, Maitland, Michael L., MD, PhD, Remick, Scot C., MD, Tang, W.H. Wilson, MD

Get full text

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study by Bible, Keith C, Dr, Suman, Vera J, Prof, Molina, Julian R, MD, Smallridge, Robert C, Prof, Maples, William J, MD, Menefee, Michael E, MD, Rubin, Joseph, Prof, Sideras, Kostandinos, MD, Morris, John C, MD, McIver, Bryan, MB, Burton, Jill K, Webster, Kevin P, Bieber, Carolyn, Traynor, Anne M, MD, Flynn, Patrick J, MD, Goh, Boon Cher, MBBS, Tang, Hui, PhD, Ivy, Susan Percy, MD, Erlichman, Charles, Prof

Get full text

A Phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow : A report of the children's cancer group by ETTINGER, L. J, IVY, P, GAYNON, P. S, ETTINGER, A. G, LIU-MARES, W, KRAILO, M. D

Get full text